Life Technologies reported $4.93M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Ardelyx USD 83.99M 7.92M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Cipla INR 13.12B 792M Jun/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.38M 12K Jun/2025
CSL USD 1.18B 201M Dec/2024
Galapagos EUR 30.67M 13.12M Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
Grifols EUR 269.48M 49.95M Dec/2024
Life Technologies USD 4.93M 1.34M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
United Therapeutics USD 212.5M 42.4M Jun/2025